![Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2012/78/1/Images/ijdvl_2012_78_1_68_90949_f8.jpg)
Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology
![Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo](https://anndermatol.org/ArticleImage/0140AD/ad-27-104-g001-l.jpg)
Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo
![Vitiligo Treatment with Monochromatic Excimer Light and Tacrolimus: Results of an Open Randomized Controlled Study | Photomedicine and Laser Surgery Vitiligo Treatment with Monochromatic Excimer Light and Tacrolimus: Results of an Open Randomized Controlled Study | Photomedicine and Laser Surgery](https://www.liebertpub.com/cms/10.1089/pho.2011.3029/asset/images/medium/figure1.gif)
Vitiligo Treatment with Monochromatic Excimer Light and Tacrolimus: Results of an Open Randomized Controlled Study | Photomedicine and Laser Surgery
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure10.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure2.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure6.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients](https://www.spandidos-publications.com/article_images/etm/15/4/etm-15-04-3981-g00.jpg)
Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients
![PDF) A comparative study of fractional carbon dioxide laser, narrowband ultraviolet B and topical tacrolimus 0.1% ointment versus narrowband ultraviolet B, topical tacrolimus 0.1% ointment in stable vitiligo PDF) A comparative study of fractional carbon dioxide laser, narrowband ultraviolet B and topical tacrolimus 0.1% ointment versus narrowband ultraviolet B, topical tacrolimus 0.1% ointment in stable vitiligo](https://www.researchgate.net/publication/339504740/figure/fig2/AS:862815942348800@1582722759208/Mucosal-vitiligo_Q320.jpg)
PDF) A comparative study of fractional carbon dioxide laser, narrowband ultraviolet B and topical tacrolimus 0.1% ointment versus narrowband ultraviolet B, topical tacrolimus 0.1% ointment in stable vitiligo
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase](https://aerolase.com/wp-content/uploads/2022/08/Figure-11-vitiligo-200x223.png)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase](https://aerolase.com/wp-content/uploads/2022/08/Figure-12-vitiligo-200x213.png)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase
![PDF] Tacrolimus Ointment Effectiveness and Safety of Tacrolimus in Vitiligo Children | Semantic Scholar PDF] Tacrolimus Ointment Effectiveness and Safety of Tacrolimus in Vitiligo Children | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/717256975271f11469f1e7ff0c272dcf33bba422/6-Figure9-1.png)
PDF] Tacrolimus Ointment Effectiveness and Safety of Tacrolimus in Vitiligo Children | Semantic Scholar
![A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 - A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 -](https://onlinelibrary.wiley.com/cms/asset/bc408870-ce96-428c-96cd-9056b31c9e33/ced12742-fig-0001-m.jpg)
A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 -
![Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines - ScienceDirect Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962204005171-gr4.jpg)
Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines - ScienceDirect
![Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962204015774-gr2.jpg)